NCT06732882 - Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

May 29, 2025

Study Completion Date

May 29, 2025

Conditions

Asthma

Interventions

DRUG

AZD4604

Participants will receive AZD4604 via Genuair/Turbuhaler device.

OTHER

Placebo

Participants will receive placebo via Genuair/Turbuhaler device.

DEVICE

Genuair

Participants will either receive AZD4604 or placebo via Genuair device.

DEVICE

Turbuhaler

Participants will receive either AZD4604 or placebo via Turbuhaler device.

Trial Locations (10)

Research Site, Berlin

Research Site, Berlin

Research Site, Großhansdorf

Research Site, Lübeck

Research Site, Frankfurt

Research Site, Cambridge

Research Site, Harrow

Research Site, Liverpool

Research Site, London

Research Site, Wythenshawe